NANOGP10

Across TCGA pan-cancer cohorts, NANOGP10 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated NANOGP10 data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher NANOGP10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NANOGP10 expression acts as an unfavorable survival marker, although some lineages such as OV and MESO show a favorable association.

GBM, OV, and COAD are the cancer types where NANOGP10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.079	0.415	.003	27	view →
OV	DFS	Tertile	All	0.680	0.374	.044	24	view →
COAD	OS	Tertile	III,IV	0.239	0.791	.014	18	view →
SKCM	OS	Tertile	IV	0.226	0.613	.034	9	view →
MESO	DFS	Tertile	All	1.000	0.179	.041	9	view →
LUAD	DFS	Tertile	II,III,IV	0.286	0.550	.049	9	view →
LIHC	DFS	Tertile	II,III,IV	0.247	0.432	.044	9	view →
KIRC	DFS	Tertile	III,IV	1.000	0.603	.049	6	view →
SARC	OS	Tertile	All	0.997	0.825	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

NANOGP10–GBM (OS)

Open the GBM breakdown →